Decrease in LDL and increase in HDL concentrations in type II hyperlipoproteinaemic patients on low-dose combination therapy of cholestyramine and Complamin.

Source:http://linkedlifedata.com/resource/pubmed/id/3279969

Download in:

View as

General Info

PMID
3279969